Complete microscale profiling of tumor microangiogenesis: a microradiological methodology reveals fundamental aspects of tumor angiogenesis and yields an array of quantitative parameters for its characterization

Biotechnol Adv. 2013 May-Jun;31(3):396-401. doi: 10.1016/j.biotechadv.2011.12.001. Epub 2011 Dec 14.

Abstract

Complete profiling would substantially facilitate the fundamental understanding of tumor angiogenesis and of possible anti-angiogenesis cancer treatments. We developed an integrated synchrotron-based methodology with excellent performances: detection of very small vessels by high spatial resolution (~1 μm) and nanoparticle contrast enhancement, in vivo dynamics investigations with high temporal resolution (~1 ms), and three-dimensional quantitative morphology parametrization by computer tracing. The smallest (3-10 μm) microvessels were found to constitute >80% of the tumor vasculature and exhibit many structural anomalies. Practical applications are presented, including vessel microanalysis in xenografted tumors, monitoring the effects of anti-angiogenetic agents and in vivo detection of tumor vascular rheological properties.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Angiogenesis Inhibitors / pharmacology
  • Animals
  • Antibodies, Monoclonal, Humanized / pharmacology
  • Barium Sulfate
  • Bevacizumab
  • Contrast Media
  • Diagnostic Imaging / instrumentation
  • Diagnostic Imaging / methods*
  • Humans
  • Imaging, Three-Dimensional / methods
  • Mice
  • Mice, Inbred BALB C
  • Microradiography / instrumentation
  • Microradiography / methods*
  • Microvessels / drug effects
  • Microvessels / pathology*
  • Nanoparticles
  • Neovascularization, Pathologic / diagnosis*
  • Neovascularization, Pathologic / drug therapy
  • Neovascularization, Pathologic / pathology
  • Synchrotrons
  • Tumor Microenvironment
  • Xenograft Model Antitumor Assays

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Contrast Media
  • Barium Sulfate
  • Bevacizumab